Drug Regulators, EMA, Publish Overview of Comments Received on “Guideline on the Clinical Evaluation of Antifungal Agents for the Treatment and Prophylaxis of Invasive Fungal Disease”
Full Text Here
Interested parties (organisations or individuals) that commented on the draft document as released for consultation.
1 EFPIA
EFPIA welcomes the revision of the existing guideline on the clinical evaluation of antifungal agents for the treatment and prophylaxis of invasive fungal disease. EFPIA wishes to raise the following key comments, regarding some of the concepts presented in the draft guideline. These key points are followed by other important comments presented according to the different sections of the draft guideline.
Click Here for – Drug Development Services – Click Here
Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.
Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!
Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.
“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”
